JP2023503611A5 - - Google Patents
Info
- Publication number
- JP2023503611A5 JP2023503611A5 JP2022530672A JP2022530672A JP2023503611A5 JP 2023503611 A5 JP2023503611 A5 JP 2023503611A5 JP 2022530672 A JP2022530672 A JP 2022530672A JP 2022530672 A JP2022530672 A JP 2022530672A JP 2023503611 A5 JP2023503611 A5 JP 2023503611A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026000091A JP2026062897A (ja) | 2019-11-26 | 2026-01-05 | 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962940720P | 2019-11-26 | 2019-11-26 | |
| US201962940735P | 2019-11-26 | 2019-11-26 | |
| US62/940,720 | 2019-11-26 | ||
| US62/940,735 | 2019-11-26 | ||
| PCT/US2020/062082 WO2021108447A1 (en) | 2019-11-26 | 2020-11-24 | Methods for treating and/or preventing idiopathic pneumonia syndrome (ips) and/or capillary leak syndrome (cls) and/or engraftment syndrome (es) and/or fluid overload (fo) associated with hematopoietic stem cell transplant |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026000091A Division JP2026062897A (ja) | 2019-11-26 | 2026-01-05 | 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503611A JP2023503611A (ja) | 2023-01-31 |
| JP2023503611A5 true JP2023503611A5 (https=) | 2023-07-27 |
| JPWO2021108447A5 JPWO2021108447A5 (https=) | 2023-07-27 |
Family
ID=76130747
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530672A Pending JP2023503611A (ja) | 2019-11-26 | 2020-11-24 | 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法 |
| JP2026000091A Pending JP2026062897A (ja) | 2019-11-26 | 2026-01-05 | 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026000091A Pending JP2026062897A (ja) | 2019-11-26 | 2026-01-05 | 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20220064330A1 (https=) |
| EP (1) | EP4065165A4 (https=) |
| JP (2) | JP2023503611A (https=) |
| KR (1) | KR20220104201A (https=) |
| CN (1) | CN115335077A (https=) |
| AU (1) | AU2020391175A1 (https=) |
| BR (1) | BR112022010078A2 (https=) |
| CA (1) | CA3159152A1 (https=) |
| CL (4) | CL2022001355A1 (https=) |
| IL (1) | IL293363A (https=) |
| JO (1) | JOP20220113A1 (https=) |
| MX (1) | MX2022006334A (https=) |
| WO (1) | WO2021108447A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023108028A2 (en) | 2021-12-10 | 2023-06-15 | Omeros Corporation | Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7919094B2 (en) * | 2004-06-10 | 2011-04-05 | Omeros Corporation | Methods for treating conditions associated with MASP-2 dependent complement activation |
| EP2704743B1 (en) * | 2011-05-04 | 2020-03-11 | Omeros Corporation | Compositions for inhibiting masp-2 dependent complement acitivation |
| CN108472347B (zh) * | 2015-11-09 | 2023-09-05 | 奥默罗斯公司 | 用于治疗与masp-2依赖性补体活化相关的病况的方法 |
| US10736960B2 (en) * | 2016-01-05 | 2020-08-11 | Omeros Corporation | Methods for inhibiting fibrosis in a subject in need thereof |
| RU2018145364A (ru) * | 2016-06-27 | 2020-07-28 | Ачиллион Фармасьютикалс, Инк. | Хиназолиновые и индольные соединения для лечения медицинских нарушений |
| JOP20170170B1 (ar) * | 2016-08-31 | 2022-09-15 | Omeros Corp | صيغ لجسم مضاد تثبيطية لـ masp-2 بتركيز عالي ولزوجة منخفضة وأطقم، وطرق |
| EP3526249A4 (en) * | 2016-10-17 | 2020-07-01 | Musc Foundation for Research Development | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INJURY ASSOCIATED WITH A GRAFT |
| CA3055781A1 (en) * | 2017-03-14 | 2018-09-20 | Bioverativ Usa Inc. | Methods for treating complement-mediated diseases and disorders |
| TWI818919B (zh) * | 2017-08-15 | 2023-10-21 | 美商歐米諾斯公司 | 用於治療和／ 或預防與造血幹細胞移植有關的移植物抗宿主病和／ 或瀰漫性肺泡出血和／ 或靜脈閉塞性病的方法 |
| EP3717004A4 (en) * | 2017-12-01 | 2021-12-01 | Children's Hospital Medical Center | COMPOSITIONS FOR BLOCKING INTERERONS AND THEIR METHODS OF USE |
-
2020
- 2020-11-24 WO PCT/US2020/062082 patent/WO2021108447A1/en not_active Ceased
- 2020-11-24 US US17/103,672 patent/US20220064330A1/en not_active Abandoned
- 2020-11-24 CA CA3159152A patent/CA3159152A1/en active Pending
- 2020-11-24 BR BR112022010078A patent/BR112022010078A2/pt unknown
- 2020-11-24 CN CN202080094868.6A patent/CN115335077A/zh active Pending
- 2020-11-24 IL IL293363A patent/IL293363A/en unknown
- 2020-11-24 MX MX2022006334A patent/MX2022006334A/es unknown
- 2020-11-24 JP JP2022530672A patent/JP2023503611A/ja active Pending
- 2020-11-24 AU AU2020391175A patent/AU2020391175A1/en active Pending
- 2020-11-24 KR KR1020227020672A patent/KR20220104201A/ko active Pending
- 2020-11-24 EP EP20892727.7A patent/EP4065165A4/en active Pending
- 2020-11-24 JO JOP/2022/0113A patent/JOP20220113A1/ar unknown
-
2022
- 2022-05-24 CL CL2022001355A patent/CL2022001355A1/es unknown
-
2024
- 2024-01-12 US US18/411,789 patent/US20240218080A1/en not_active Abandoned
- 2024-05-13 CL CL2024001421A patent/CL2024001421A1/es unknown
- 2024-05-13 CL CL2024001420A patent/CL2024001420A1/es unknown
- 2024-05-13 CL CL2024001422A patent/CL2024001422A1/es unknown
-
2026
- 2026-01-05 JP JP2026000091A patent/JP2026062897A/ja active Pending